Department of Surgery, Surgical Outcomes Analysis and Research, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Cancer. 2010 Apr 1;116(7):1733-8. doi: 10.1002/cncr.24904.
: There is a wide spectrum of disease burden in hepatocellular carcinoma accompanied by several options for surgical management. However, the associated mortality of such procedures is not well defined. Accurate predictions of patients' perioperative risk would be helpful to guide decision making.
: The Nationwide Inpatient Sample was queried for data from 1998 to 2005. A cohort of patients who were discharged for hepatic procedures with a diagnosis of primary liver neoplasm was assembled. Procedures were categorized as hepatic lobectomy, wedge resection, or enucleation/ablation. Logistic regression and bootstrap methods were used to create an integer risk score for estimating the risk of in-hospital mortality using procedure type, patient demographics, comorbidities, and hospital type. A randomly selected sample of 80% of the cohort (n = 2263) was used to create the score with validation conducted in the remaining 20% (n = 571).
: In total, 2834 patient discharges were identified. Overall in-hospital mortality was 6.52%. Factors that were included in the final model were age, sex, Charlson comorbidity score, procedure type, and teaching hospital status. Integer values were assigned to these characteristics and were used to calculate an additive score. Four clinically relevant score groups were assembled to stratify the risk of in-hospital mortality, with a 19-fold gradient of mortality that ranged from 1.5% to 28.3%. In the derivation set, as in the validation set, the score discriminated well with c-statistics of 0.75 and 0.73, respectively.
: The current results indicated that an integer-based risk score can be used to predict in-hospital mortality after surgery for hepatocellular carcinoma, and it may be useful for preoperative risk stratification and patient counseling. Cancer 2010. (c) 2010 American Cancer Society.
肝细胞癌的疾病负担范围广泛,有多种手术治疗方案可供选择。然而,这些手术的相关死亡率尚不清楚。准确预测患者围手术期的风险将有助于指导决策。
从 1998 年至 2005 年,国家住院患者样本被查询数据。组建了一组因原发性肝肿瘤诊断而接受肝手术出院的患者队列。手术方式分为肝叶切除术、楔形切除术或肝切除术/消融术。使用逻辑回归和引导方法,根据手术类型、患者人口统计学、合并症和医院类型,创建一个整数风险评分,以估计住院死亡率的风险。队列的 80%(n=2263)的随机样本用于创建评分,其余 20%(n=571)的样本用于验证。
共确定了 2834 例患者出院。总的院内死亡率为 6.52%。纳入最终模型的因素包括年龄、性别、Charlson 合并症评分、手术类型和教学医院状况。为这些特征分配整数值,并用于计算加和评分。将四个临床相关的评分组组合在一起,以分层院内死亡率的风险,死亡率从 1.5%到 28.3%不等,呈 19 倍梯度。在推导组和验证组中,评分的区分度均良好,C 统计量分别为 0.75 和 0.73。
目前的结果表明,基于整数的风险评分可用于预测肝细胞癌手术后的院内死亡率,并且可能有助于术前风险分层和患者咨询。癌症 2010。(c)2010 年美国癌症协会。